« Back
Home /
Ertumaxomab

Ertumaxomab

Item no.	HY-P99290-1mg
Manufacturer	MedChem Express
CASRN	509077-99-0
Amount	1 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitor
Specific against	other
Smiles	[Ertumaxomab]
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Anti-Human CD22 Recombinant Antibody
Available
Product Description	Ertumaxomab (Anti-Human CD22 Recombinant Antibody) is a bispecific antibody targeting HER2/neu and CD3. Ertumaxomab activates Fcγ type I/III-receptors, forming a tri-cell complex among tumour cell, T cell and accessory cell. Ertumaxomab has been used to research breast cancer.
StorageTemperature	Please store the product under the recommended conditions in the Certificate of Analysis.
Clinical Information	No Development Reported
Research Area	Cancer
Target	EGFR; CD22
Pathway	JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Immunology/Inflammation

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 mg

available

Request delivery time